NCR Tables - Distribution By Histopathology Findings

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
M03AX01	NEURONOX	BioTech	Clostridium botulinum type A neurotoxin complex - 50units	50units	Injectable lyophilised powder for solution	8,904,323 L.L
L01BC05	GEMTABINE 200	G	Gemcitabine HCl - 200mg	200mg	Injectable lyophilised powder for solution	1,343,843 L.L
L01BC05	GEMTABINE 1000	G	Gemcitabine HCl - 1,000mg	1,000mg	Injectable lyophilised powder for solution	4,882,628 L.L
L01BC08	DACOGEN	B	Decitabine - 50mg	50mg	Injectable lyophilised powder for solution	87,048,758 L.L
L01BC08	DACOGEN	B	Decitabine - 50mg	50mg	Injectable lyophilised powder for solution	87,048,758 L.L
L01XA03	OXALIPLATINO GP PHARM	G	Oxaliplatin - 100mg	100mg	Injectable lyophilised powder for solution	6,199,145 L.L
L01XA03	OXALTIE	G	Oxaliplatin - 100mg	100mg	Injectable lyophilised powder for solution	5,915,595 L.L
J02AX05	MYCAMINE	B	Micafungin (sodium) - 50mg	50mg	Injectable lyophilised powder for solution	13,170,341 L.L
L01XA03	OXALIPLATINO GP PHARM	G	Oxaliplatin - 50mg	50mg	Injectable lyophilised powder for solution	2,957,797 L.L
L01XA03	OXALTIE	G	Oxaliplatin - 50mg	50mg	Injectable lyophilised powder for solution	2,957,797 L.L
J05AB01	ASIMPLEX	G	Aciclovir - 250mg	250mg	Injectable lyophilised powder for solution	278,175 L.L
L01XG01	VELCADE	B	Bortezomib - 3.5mg	3.5mg	Injectable lyophilised powder for solution	23,616,000 L.L
A16AB02	CEREZYME	B	Imiglucerase - 400IU	400IU	Injectable lyophilised powder for solution	128,412,818 L.L
L01XG01	BORTEZOMIB NEAPOLIS	G	Bortezomib - 3.5mg	3.5mg	Injectable lyophilised powder for solution	14,169,600 L.L
L01CE01	HYCAMTIN IV	B	Topotecan HCl - 4mg	4mg	Injectable lyophilised powder for solution	52,580,031 L.L
L01CE01	HYCAMTIN IV	B	Topotecan HCl - 4mg	4mg	Injectable lyophilised powder for solution	52,580,031 L.L
J05AB16	FLEXIVIR	G	Remdesivir - 50mg	50mg	Injectable lyophilised powder for solution	4,837,833 L.L
L01XX02	ERWINASE	BioTech	Erwinia L-asparaginase - 10,000IU	10,000IU	Injectable lyophilised powder for solution	444,434,845 L.L
L01DC01	BLEOCIN	B	Bleomycin (sulfate), - 15mg	15mg	Injectable lyophilised powder for solution	2,109,833 L.L
J01AA12	TYGACIL	B	Tigecycline - 50mg	50mg	Injectable lyophilised powder for solution	25,356,524 L.L
J01AA12	TAGIX	G	Tigecycline - 50mg	50mg	Injectable lyophilised powder for solution	2,436,386 L.L
L01XG01	BORTEZOMIB NEAPOLIS	G	Bortezomib - 3.5mg	3.5mg	Injectable lyophilised powder for solution	L.L
A02BC01	IPPROTON	G	Omeprazole - 40mg	40mg	Injectable lyophilised powder	6,533,762 L.L
L01BA04	PEMETREXED GP PHARM	G	Pemetrexed (disodium) - 500mg	500mg	Injectable lyophilised powder	46,641,484 L.L
J01XA02	TEICO MEDIS 400	G	Teicoplanin - 400mg	400mg	Injectable lyophilised powder	1,157,048 L.L
J01XA02	TEICO MEDIS 200	G	Teicoplanin - 200mg	200mg	Injectable lyophilised powder	428,686 L.L
L01FD01	OGIVRI	BioTech	Trastuzumab - 440mg	440mg	Injectable lyophilised powder	80,027,615 L.L
L01FD01	TRASTUREL	BioTech	Trastuzumab - 440mg	440mg	Injectable lyophilised powder	52,047,114 L.L
L01BC05	HAXANIT	G	Gemcitabine (HCl) - 200mg	200mg	Injectable lyophilised powder	1,411,035 L.L
L01BC05	HAXANIT	G	Gemcitabine (HCl) - 1g	1g	Injectable lyophilised powder	6,829,408 L.L

جداول بيانية لسجل الوطني للسرطان - توزيع الحالات حسب خصائص الانسجة